Polyclonal Antibody to Leucine Rich Repeat Containing G Protein Coupled Receptor 5 (LGR5)
| Code | Size | Price |
|---|
| PAG047Hu01-20ul | 20ul | £103.00 |
Quantity:
| PAG047Hu01-100ul | 100ul | £199.00 |
Quantity:
| PAG047Hu01-200ul | 200ul | £271.00 |
Quantity:
| PAG047Hu01-1ml | 1ml | £633.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Host Type: Rabbit
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Applications:
- Immunocytochemistry (ICC)
- Immunohistochemistry (IHC)
- Immunoprecipitation (IP)
- Western Blot (WB)
Documents
Further Information
Alternative Names:
FEX; GPR49; GPR67; HG38; G Protein-Coupled Receptor 49
Buffer Formulation:
0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
Immunogen:
RPG047Hu01-Recombinant Leucine Rich Repeat Containing G Protein Coupled Receptor 5 (LGR5)
Item Name:
Leucine Rich Repeat Containing G Protein Coupled Receptor 5
Source:
Polyclonal antibody preparation
Subcategory:
Polyclonal antibody preparation
USAGE:
Western blotting: 0.5-2ug/mL<br/>Immunohistochemistry: 5-20ug/mL<br/>Immunocytochemistry: 5-20ug/mL<br/>Optimal working dilutions must be determined by end user.
Related Products
| Product Name | Product Code | Supplier | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Immunogen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Recombinant Leucine Rich Repeat Containing G Protein Coupled Receptor 5 (LGR5) | RPG047Hu01 | Cloud-Clone Corp. | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||